Moreover, the modulated bacteria and microbial metabolites were notably correlated with the amelioration of NAFLD-related indices and activation of the hepatic TLR4/NF-κB/NLRP3 pathway. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.